您的购物车当前为空
别名 XMT-2056
Calotatug ginistinag (XMT-2056) 作为一款靶向HER2的抗体偶联药物 (Antibody-Drug Conjugates),其通过linker (XMT-1519 conjugate-1) 连接STING激动剂 (STING agonist-20),形成高效载荷。该药物展现了潜在的抗肿瘤效果及免疫激活能力。
Calotatug ginistinag (XMT-2056) 作为一款靶向HER2的抗体偶联药物 (Antibody-Drug Conjugates),其通过linker (XMT-1519 conjugate-1) 连接STING激动剂 (STING agonist-20),形成高效载荷。该药物展现了潜在的抗肿瘤效果及免疫激活能力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | 待询 | 待询 | |
| 5 mg | 待询 | 待询 |
Calotatug ginistinag 相关产品
| 产品描述 | Calotatug ginistinag (XMT-2056) is an antibody-drug conjugate (ADC) aimed at targeting HER2. It is connected by a linker (XMT-1519 conjugate-1) to an effective payload that includes a STING agonist (STING agonist-20), presenting potential in immune activation and anti-tumor activity. |
| 别名 | XMT-2056 |
| CAS No. | 2847102-44-5 |
| 存储 | -20°C for 1 year | Shipping with blue ice. |
评论内容